-
1
Enhancing doxorubicin sensitivity in osteosarcoma via iRGD-modified biomimetic nanoparticles targeting MCAM m6A modification
Published 2025-07-01Subjects: Get full text
Article -
2
SH3GL1‐activated FTH1 inhibits ferroptosis and confers doxorubicin resistance in diffuse large B‐cell lymphoma
Published 2025-03-01Subjects: Get full text
Article